Properties of Angiotensin Ⅰ-Converting Enzyme(ACE)

QR Code

Properties of Angiotensin Ⅰ-Converting Enzyme(ACE)

None

Saved in:

Bibliographic Details
Main Author:	Takenaka, Tetsuo
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Life Sciences
Online Access:	https://www.intechopen.com/chapters/15700
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

An angiotensin-converting enzyme inhibitor in the combination treatment of rheumatoid arthritis
by: E. B. Komarova, et al.
Published: (2017-09-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

I/D POLYMORPHISM OF ANGIOTENSINE CONVERTING ENZYME IN CHD PATIENTS OF DIFFERENT AGE AND GENDER
by: T. Yu. Rebrova, et al.
Published: (2014-10-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION
by: D. B. Nebieridze, et al.
Published: (2015-12-01)

EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE
by: Jose Lopez-Sendon, et al.
Published: (2015-12-01)

The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis.
by: Ayanda Trevor Mnguni, et al.
Published: (2015-01-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

Modified spectrophotometric method for assay of angiotensin I-converting enzyme inhibitory activity of foodderived peptides
by: GAO Dan-dan, et al.
Published: (2011-03-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
by: O. Yu. Shaidyuk, et al.
Published: (2013-12-01)

A ROLE OF ANGIOTENSIN-CONVERTING ENZYME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE SUMMARY
by: N. D. Elshin, et al.
Published: (2017-09-01)

Novel Whey Fermented Beverage Enriched with a Mixture of Juice Concentrates: Evaluation of Antimicrobial, Antioxidant, and Angiotensin I Converting Enzyme Inhibitory (ACE) Activities Before and After Simulated Gastrointestinal Digestion
by: Paschalia Kotsaki, et al.
Published: (2025-06-01)

Angiotensin I-converting enzyme gene plays a crucial role in the pathology of carcinomas in colorectal cancer
by: Keqian Zhang, et al.
Published: (2019-12-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-01-01)

Variation of Concentrations of Angiotensin II, AngiotensinConverting Enzyme and Matrix Metalloprotease-9 in Tears and Serum of Patients with Diabetic Retinopathy
by: V. V. Neroev, et al.
Published: (2020-12-01)

Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
by: Xiang Ma, et al.
Published: (2023-07-01)

ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE
by: E. A. Ryabikhin, et al.
Published: (2016-01-01)

CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS
by: L. I. Katelnitskaya, et al.
Published: (2015-12-01)

EFFICACY OF A NON-LIPOPHILIC ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND ITS POSSIBLE ADVANTAGES
by: N. A. Mazur
Published: (2003-08-01)

The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience
by: А. О. Shevchenko, et al.
Published: (2019-01-01)

Angiotensin Converting Enzyme Inhibitors: Interaction Issues in Patients with Glaucoma and Arterial Hypertension. Review
by: S. I. Makogon, et al.
Published: (2023-12-01)

Metabolic Optimization by Enzyme-Enzyme and Enzyme-Cytoskeleton Associations
by: Araiza-Olivera, Daniela, et al.
Published: (2012)

The role of the classical renin–angiotensin system and angiotensin-converting enzyme 2/Ang(1–7)/Mas axis in pulmonary fibrosis
by: Changhui Lang, et al.
Published: (2025-07-01)

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
by: Mingfei Li, et al.
Published: (2021-01-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY
by: S. Yu. Martsevich
Published: (2015-09-01)

A GWAS of angiotensin-converting enzyme inhibitor-induced angioedema in a South African population
by: Jacquiline W. Mugo, PhD, et al.
Published: (2025-08-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: A. G. Evdokimova, et al.
Published: (2013-02-01)

DEVELOPMENT OF METHODS OF SIMULATION OF THE INTERACTION OF BIOLOGICALLY ACTIVE SUBSTANCES WITH THE ACTIVE CENTER OF ANGIOTENSIN-CONVERTING ENZYME
by: A. A. Glushko, et al.
Published: (2017-10-01)

Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in Older Patients with acute Myocardial Infarction after a Successful Stent Implantation
by: Geum Ko, et al.
Published: (2025-06-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION
by: K. Yu. Nikolaev, et al.
Published: (2016-01-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: K. A. Gyamdzhyan, et al.
Published: (2015-12-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

The efficacy of angiotensin-converting enzyme inhibitors in preventing postoperative tendon adhesion formation: An experimental study in rats
by: Tuğçe Yasak, et al.
Published: (2022-01-01)

TREATMENT ESTIMATION OF DIABETIC NEPHROPATHY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS BY ANGIOTENSIN CONVERTING ENZYME INHIBITORS
by: V.N. Panfilova, et al.
Published: (2008-11-01)